Depot antipsychotic drugs and prevention of psychotic relapse
- PMID: 1684307
Depot antipsychotic drugs and prevention of psychotic relapse
Similar articles
-
A brief history of depot neuroleptics.J Clin Psychiatry. 1984 May;45(5 Pt 2):3-4. J Clin Psychiatry. 1984. PMID: 6143745
-
[Withdrawal of delayed-action neuroleptics in psychotic patients].Ann Med Psychol (Paris). 1979 Mar-Apr;137(3-4):351-5. Ann Med Psychol (Paris). 1979. PMID: 40514 French. No abstract available.
-
Depot antipsychotics in practice. Their rôle in schizophrenia and related psychoses.Int Clin Psychopharmacol. 1986 Jul;1 Suppl 1:1-78. Int Clin Psychopharmacol. 1986. PMID: 2881965 No abstract available.
-
[Indications for, limitations, and hazards of neuroleptic agents].Ned Tijdschr Geneeskd. 1980 Apr 26;124(17):647-53. Ned Tijdschr Geneeskd. 1980. PMID: 6104304 Review. Dutch. No abstract available.
-
Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.J Psychopharmacol. 2006 Nov;20(6 Suppl):20-37. doi: 10.1177/1359786806071243. J Psychopharmacol. 2006. PMID: 17046985 Review.
Cited by
-
Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.Pharmacoeconomics. 2005;23 Suppl 1:75-89. doi: 10.2165/00019053-200523001-00007. Pharmacoeconomics. 2005. PMID: 16416763
-
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US.Pharmacoeconomics. 2005;23(3):299-314. doi: 10.2165/00019053-200523030-00009. Pharmacoeconomics. 2005. PMID: 15836010
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical